Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.17
-0.0800-1.10%
Volume:49.88K
Turnover:369.89K
Market Cap:42.01M
PE:-0.63
High:7.60
Open:7.20
Low:7.17
Close:7.25
Loading ...

Atara Biotherapeutics Inc - Workforce Reduction Expected to Complete by June 2025

THOMSON REUTERS
·
04 Mar

BRIEF-Atara Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
08 Feb

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
08 Feb

Atara reduction in workforce to impact 50% of current employees

TIPRANKS
·
28 Jan

Atara Biotherapeutics Inc - to Reduce Workforce by 50%

THOMSON REUTERS
·
28 Jan

Atara Biotherapeutics Faces Uncertainty Amid FDA Clinical Hold and Financing Needs, Resulting in Hold Rating

TIPRANKS
·
22 Jan

Atara Biotherapeutics price target lowered to $5 from $10 at Stifel

TIPRANKS
·
22 Jan

Atara Biotherapeutics Shares Tumble After FDA Places Clinical Hold on Investigational New Drug Applications

MT Newswires Live
·
22 Jan

Rodman & Renshaw Downgrades Atara Biotherapeutics to Neutral From Buy, $7 Price Target

MT Newswires Live
·
22 Jan

Atara Biotherapeutics downgraded to Neutral from Buy at Rodman & Renshaw

TIPRANKS
·
22 Jan

FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs

Benzinga
·
22 Jan

Atara Biotherapeutics Shares Fall 4.7% After FDA Puts Clinical Hold on Co's Cancer Therapy Trials

THOMSON REUTERS
·
21 Jan

BUZZ-Atara Biotherapeutics falls after FDA puts clinical hold on cancer therapy trials

Reuters
·
21 Jan

Atara's New Drug Applications Placed on Hold by FDA

Dow Jones
·
21 Jan

Atara Biotherapeutics Shares Down 4.4% Premarket After US FDA Places Clinical Hold on Cancer Therapy Trials

THOMSON REUTERS
·
21 Jan

BRIEF-Atara Biotherapeutics Provides Update On Clinical Programs For Ebvallo™ And Ata3219

Reuters
·
21 Jan